A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study - Concepedia

Concepedia

Publication | Closed Access

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

122

Citations

22

References

2021

Year

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison, Hania Al‐Hallaq, Philip C. Hoffman, Michael J. Jelinek, Aditya Juloori, J.M. Melotek, Septimiu Murgu, J. Partouche,

Journal of Thoracic Oncology

Adaptive RadiotherapyRadiation MedicineRadiation TherapyMedicineSequential IpilimumabPharmacotherapyStereotactic Body RadiotherapyOncologyRadiation OncologyPhase 1Treatment Verification

References

	Year	Citations

Page 1

Page 1